Nicolas Rodondi Selected Research

Thyrotropin (Thyroid-Stimulating Hormone)

11/2021	Association of Thyroid Dysfunction With Cognitive Function: An Individual Participant Data Analysis.
1/2021	Effect of Levothyroxine Therapy on the Development of Depressive Symptoms in Older Adults With Subclinical Hypothyroidism: An Ancillary Study of a Randomized Clinical Trial.
1/2021	Challenges in the Management of Atrial Fibrillation With Subclinical Hyperthyroidism.
1/2020	The Impact of Levothyroxine on Cardiac Function in Older Adults With Mild Subclinical Hypothyroidism: A Randomized Clinical Trial.
2/2018	[Subclinical hypothyroidism : should we still treat elderly patients? Clinical implications of a new trial in primary care].
1/2018	Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update.
11/2017	Thyroid Function Within the Normal Range, Subclinical Hypothyroidism, and the Risk of Atrial Fibrillation.
2/2017	Study protocol; Thyroid hormone Replacement for Untreated older adults with Subclinical hypothyroidism - a randomised placebo controlled Trial (TRUST).
1/2017	Thyroid Hormone Therapy for Older Adults with Subclinical Hypothyroidism.
1/2017	Thyroid Function Tests in the Reference Range and Fracture: Individual Participant Analysis of Prospective Cohorts.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolas Rodondi Research Topics

Disease

41	Hypothyroidism 01/2022 - 11/2005
31	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 01/2005
28	Acute Coronary Syndrome 10/2021 - 06/2008
20	Myocardial Infarction 01/2022 - 04/2006
17	Stroke (Strokes) 01/2022 - 11/2005
16	Coronary Disease (Coronary Heart Disease) 01/2020 - 11/2005
14	Hypertension (High Blood Pressure) 01/2022 - 04/2006
14	Hyperthyroidism 11/2021 - 04/2007
13	Venous Thromboembolism 12/2021 - 01/2015
13	Heart Failure 11/2021 - 11/2005
13	Hemorrhage 11/2021 - 08/2012
13	Atherosclerosis 01/2021 - 11/2006
11	Frailty 10/2022 - 01/2017
11	Neoplasms (Cancer) 10/2021 - 12/2010
9	Malnutrition (Nutritional Deficiencies) 03/2022 - 01/2019
9	Diabetes Mellitus 01/2020 - 04/2006
8	ST Elevation Myocardial Infarction 10/2021 - 06/2015
8	Atrial Fibrillation 09/2021 - 01/2020
6	Anemia 01/2022 - 01/2015
6	Inflammation (Inflammations) 10/2021 - 07/2009
6	Death (Near-Death Experience) 05/2021 - 06/2015
6	Chronic Disease (Chronic Diseases) 01/2021 - 04/2009
6	Coronary Artery Disease (Coronary Atherosclerosis) 08/2020 - 08/2013
6	Pulmonary Embolism 09/2019 - 01/2014
5	Pneumonia (Pneumonitis) 11/2021 - 06/2014
4	Chronic Renal Insufficiency 01/2022 - 11/2016
4	Dyslipidemias (Dyslipidemia) 03/2020 - 04/2006
4	Body Weight (Weight, Body) 02/2017 - 04/2002
3	Critical Illness (Critically Ill) 03/2022 - 01/2019
3	Chest Pain (Chest Pains) 03/2021 - 02/2016
3	Skeletal Abnormalities Mandibular Hypoplasia Auditory Canal Atresia Short Stature 01/2021 - 01/2016
3	Fatigue 01/2020 - 02/2017
3	Transient Ischemic Attack 01/2020 - 08/2012
3	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 02/2018 - 03/2016
3	Carotid Artery Diseases 01/2018 - 04/2007
3	Hypercholesterolemia 03/2016 - 04/2002
2	Fibrosis (Cirrhosis) 01/2022 - 03/2012
2	Peripheral Arterial Disease 10/2021 - 11/2005
2	Brain Infarction 09/2021 - 02/2021
2	Drug-Related Side Effects and Adverse Reactions 03/2020 - 11/2018
2	Rhabdomyolysis 03/2020 - 03/2010
2	Hypertriglyceridemia 03/2020 - 04/2002
2	Vascular Diseases (Vascular Disease) 01/2020 - 12/2010
2	Thrombosis (Thrombus) 09/2018 - 01/2018
2	Hyperlipidemias (Hyperlipidemia) 02/2018 - 04/2002
2	Alcoholism (Alcohol Abuse) 01/2017 - 08/2012

Drug/Important Bio-Agent (IBA)

33	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2022 - 11/2005
24	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2022 - 02/2009
23	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2021 - 11/2005
17	Thyroid HormonesIBA 01/2022 - 04/2007
16	LipidsIBA 01/2021 - 04/2002
13	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2013
13	LDL CholesterolIBA 01/2021 - 03/2010
12	C-Reactive ProteinIBA 10/2021 - 03/2010
8	omega-Chloroacetophenone (Mace)IBA 01/2020 - 02/2017
7	CreatinineIBA 01/2022 - 04/2007
7	AnticoagulantsIBA 01/2021 - 08/2012
6	Ezetimibe (Zetia)FDA Link 01/2022 - 01/2016
6	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 04/2002
5	PCSK9 InhibitorsIBA 01/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2019
4	Antihypertensive Agents (Antihypertensives)IBA 10/2022 - 01/2017
4	pro-brain natriuretic peptide (1-76)IBA 10/2021 - 03/2018
4	Troponin T (Troponin T1)IBA 10/2021 - 09/2016
4	Interleukin-6 (Interleukin 6)IBA 03/2021 - 03/2010
4	SubtilisinIBA 01/2021 - 01/2016
4	oxidized low density lipoproteinIBA 01/2020 - 01/2016
4	Hormones (Hormone)IBA 02/2018 - 08/2012
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2012 - 01/2005
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 06/2014
3	Hemoglobins (Hemoglobin)IBA 01/2022 - 01/2018
3	Cystatin CIBA 01/2022 - 04/2007
3	Vitamin K FDA Link 11/2021 - 01/2015
3	trimethyloxamine (trimethylamine N-oxide)IBA 10/2021 - 03/2017
3	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2021 - 01/2016
3	HDL CholesterolIBA 07/2019 - 04/2002
3	Triglycerides (Triacylglycerol)IBA 07/2019 - 04/2002
3	CholesterolIBA 03/2016 - 04/2002
3	Adenosine Triphosphate (ATP)IBA 06/2012 - 02/2009
2	Prednisone (Sone)FDA LinkGeneric 11/2021 - 04/2015
2	GlucocorticoidsIBA 11/2021 - 01/2019
2	Cysteine (L-Cysteine)FDA Link 10/2021 - 12/2017
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2021 - 09/2019
2	TroponinIBA 10/2021 - 01/2017
2	EnzymesIBA 10/2021 - 10/2017
2	Anti-Arrhythmia AgentsIBA 08/2020 - 01/2020
2	Vitamin D FDA LinkGeneric 11/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 01/2018
2	fibrin fragment D (D-dimer)IBA 10/2017 - 01/2017

Therapy/Procedure

37	Therapeutics 03/2022 - 04/2002
10	Nutritional Support (Artificial Feeding) 01/2022 - 01/2019
9	Polypharmacy 01/2021 - 01/2015
8	Secondary Prevention 03/2022 - 11/2006
6	Percutaneous Coronary Intervention 10/2021 - 01/2016
6	Length of Stay 01/2021 - 04/2006
5	Cardiac Rehabilitation 01/2023 - 01/2016
3	Activities of Daily Living (ADL) 01/2021 - 09/2012
2	Cardiopulmonary Resuscitation (CPR) 12/2021 - 10/2021
2	Inappropriate Prescribing 03/2020 - 11/2016
2	Ambulatory Care (Outpatient Care) 12/2019 - 11/2009